Community Investing Ideas

Global Weekly Picks

CA$5.07
FV
68.0% undervalued intrinsic discount
13.7k
users have viewed this narrative
40users have liked this narrative
1users have commented on this narrative
279users have followed this narrative
US$85
FV
90.6% undervalued intrinsic discount
1.7k
users have viewed this narrative
20users have liked this narrative
1users have commented on this narrative
81users have followed this narrative
€89.45
FV
21.3% undervalued intrinsic discount
5.00%
Revenue growth p.a.
243
users have viewed this narrative
2users have liked this narrative
3users have commented on this narrative
5users have followed this narrative
US$280
FV
1.8% undervalued intrinsic discount
11.71%
Revenue growth p.a.
636
users have viewed this narrative
2users have liked this narrative
1users have commented on this narrative
59users have followed this narrative
ASIC logo
Ategrity Specialty Insurance Company Holdings

ASIC is a technology-differentiated E&S insurer compounding book value with a structurally improving combined ratio

ASIC is a technology-differentiated E&S insurer compounding book value at 15–20%+ ROE with a structurally improving combined ratio — but Zimmer's controlling ownership, a $300M affiliated investment portfolio, and a sub-one-year public track record keep the multiple at 1.56x book, creating a meaningful valuation discount to specialty insurance peers if the underwriting thesis holds. Investment Thesis The combined ratio has improved from 93.9% (2024) to 87.4% (Q1 2026) while GWP grew 23%+ — a combination that suggests genuine underwriting discipline and technology-driven cost efficiency, not just cyclical tailwind The operating expense ratio (10.9% of NEP in Q1 2026) reflects the centralized, automated model's scale benefits, and further leverage is likely as premium volume grows on a largely fixed central cost base The stock trades at approximately 10x forward earnings (annualizing Q1 run rate) and 1.56x book — a substantial discount to specialty P&C peers like RLI Corp (~3x book) or Bowhead (~27x P/E), justified primarily by governance concerns and a short track record rather than fundamental underperformance AM Best's upgrade of the rating outlook to positive, combined with zero debt and a well-capitalized balance sheet ($631M equity), provides balance sheet credibility and positions ASIC to grow its premium base without additional capital Multiple expansion to 2.0–2.3x book (base case) would imply ~$28–$33/share — 35–60% upside — driven by 2–3 more years of sub-90% combined ratios building an auditable track record Risk Considerations Casualty reserve development is the primary financial risk: the long-tailed casualty book (73% of GWP) is still in early development and adverse prior-year emergence would be financially and reputationally damaging for a recently public insurer The $304M affiliated investment complex (Zimmer-controlled Utility & Infrastructure fund + ZIS affiliate loan) represents ~48% of stockholders' equity in non-standard, potentially illiquid assets managed by or connected to the controlling shareholder — a structural governance risk that could persist indefinitely given Zimmer's voting majority E&S market hardness — the cyclical tailwind supporting pricing discipline and above-technical rates — is showing early signs of softening in property; a broader softening cycle would compress margins for all E&S carriers regardless of technology advantage Favorable catastrophe experience in Q1 2026 is not a durable driver; second-half cat seasons remain the primary quarterly earnings volatility source and could produce combined ratios materially above the YTD trend Controlling shareholder structure and emerging growth company disclosures limit public minority shareholder visibility and recourse; investors are largely dependent on Zimmer's goodwill in capital allocation decisions, including the affiliated investment relationshipsRead more

View narrative
US$30
34.6% undervalued intrinsic discount
Fair Value
Revenue
39.26% p.a.
Profit Margin
19.17%
Future PE
10.27x
Price in 2031
US$42.29
US$17.23
64.1% undervalued intrinsic discount
Profit Margin
25%
Future PE
34.3x
Price in 2031
US$25.63
PK₨218.03
101.6% overvalued intrinsic discount
Fair Value
Revenue
11.65% p.a.
Profit Margin
16.86%
Future PE
7.73x
Price in 2031
PK₨763.21